JP2009533355A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009533355A5 JP2009533355A5 JP2009504526A JP2009504526A JP2009533355A5 JP 2009533355 A5 JP2009533355 A5 JP 2009533355A5 JP 2009504526 A JP2009504526 A JP 2009504526A JP 2009504526 A JP2009504526 A JP 2009504526A JP 2009533355 A5 JP2009533355 A5 JP 2009533355A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- asparagine
- aspartic acid
- histidine
- tyrosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006901976 | 2006-04-13 | ||
| AU2006901976A AU2006901976A0 (en) | 2006-04-13 | Cyclised a-Conotoxin Peptides | |
| AU2006236006 | 2006-11-15 | ||
| AU2006236006A AU2006236006B2 (en) | 2006-04-13 | 2006-11-15 | Cyclised a-conotoxin peptides |
| PCT/AU2007/000439 WO2007118270A1 (en) | 2006-04-13 | 2007-04-03 | Cyclised alpha-conotoxin peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009533355A JP2009533355A (ja) | 2009-09-17 |
| JP2009533355A5 true JP2009533355A5 (enExample) | 2012-10-04 |
| JP5345929B2 JP5345929B2 (ja) | 2013-11-20 |
Family
ID=38608961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009504526A Expired - Fee Related JP5345929B2 (ja) | 2006-04-13 | 2007-04-03 | 環状アルファ−コノトキシンペプチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8354372B2 (enExample) |
| EP (1) | EP2015766B1 (enExample) |
| JP (1) | JP5345929B2 (enExample) |
| AU (1) | AU2006236006B2 (enExample) |
| WO (1) | WO2007118270A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007275764B2 (en) * | 2006-07-18 | 2013-11-14 | University Of Utah Research Foundation | Methods for treating pain and screening analgesic compounds |
| US9284358B2 (en) | 2006-07-18 | 2016-03-15 | University Of Utah Research Foundation | Conotoxin peptides |
| CN101381403B (zh) * | 2008-09-17 | 2011-03-16 | 中国人民解放军军事医学科学院生物工程研究所 | α型芋螺多肽衍生物及其应用 |
| BRPI0923177A2 (pt) * | 2008-12-19 | 2020-08-25 | Advanced Technologies And Regenerative Medicine, Llc | usos de composições para tratar dor neuropática e espacidade, as referidas composições, e kit |
| WO2011032233A1 (en) | 2009-09-21 | 2011-03-24 | The University Of Queensland | Novel omega conotoxin peptides |
| WO2014023129A1 (zh) * | 2012-08-07 | 2014-02-13 | 海南大学 | α-芋螺毒素肽、其药物组合物及用途 |
| CA3052708A1 (en) | 2016-02-16 | 2017-08-24 | The University Of Queensland | Novel alpha conotoxin peptides |
| RU2731217C2 (ru) * | 2016-11-28 | 2020-08-31 | Общество с ограниченной ответственностью "Синейро" | Аналог альфа-конотоксина RgIA для лечения боли |
| WO2024259977A1 (zh) * | 2023-06-21 | 2024-12-26 | 南京安吉生物科技有限公司 | 经修饰的多肽及其在镇痛领域的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614219A (en) * | 1991-12-05 | 1997-03-25 | Alfatec-Pharma Gmbh | Oral administration form for peptide pharmaceutical substances, in particular insulin |
| US5464633A (en) * | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
| GB9623205D0 (en) * | 1996-11-07 | 1997-01-08 | Eurand Int | Novel pharmaceutical compositions |
| US5866682A (en) * | 1997-05-15 | 1999-02-02 | University Of Utah Research Foundation | Conopeptides AuIA, AuIB and AuIC |
| AU4143999A (en) * | 1998-05-15 | 1999-12-06 | Unilever Plc | Oral composition comprising capsules |
| AUPP589598A0 (en) * | 1998-09-14 | 1998-10-08 | University Of Queensland, The | Novel peptides |
| US7316819B2 (en) * | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
| AUPR409401A0 (en) * | 2001-03-29 | 2001-04-26 | University Of Melbourne, The | Analgesic compound |
| EP1919506A1 (en) | 2005-08-02 | 2008-05-14 | Metabolic Pharmaceuticals Ltd. | Peptide conjugate for oral delivery of hydrophilic peptide analgesics |
-
2006
- 2006-11-15 AU AU2006236006A patent/AU2006236006B2/en not_active Ceased
-
2007
- 2007-04-03 WO PCT/AU2007/000439 patent/WO2007118270A1/en not_active Ceased
- 2007-04-03 JP JP2009504526A patent/JP5345929B2/ja not_active Expired - Fee Related
- 2007-04-03 EP EP07718686.4A patent/EP2015766B1/en not_active Not-in-force
- 2007-04-03 US US12/297,110 patent/US8354372B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009533355A5 (enExample) | ||
| JP2011523935A5 (enExample) | ||
| JP2011511753A5 (enExample) | ||
| JP2015502991A5 (enExample) | ||
| JP2010515686A5 (enExample) | ||
| JP2013518115A5 (enExample) | ||
| JP2011524418A5 (enExample) | ||
| JP2006514104A5 (enExample) | ||
| JP2015532307A5 (enExample) | ||
| JP2022513223A5 (enExample) | ||
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| JP2011524420A5 (enExample) | ||
| AR064555A1 (es) | Peptido wt1 restringido a hla-a*1101 y composicion farmaceutica que comprende el mismo | |
| RU2008141280A (ru) | Агонисты рецептора нейромедина u и их применение | |
| JP2013515055A5 (enExample) | ||
| RU2015143472A (ru) | Конъюгаты инсулин-инкретин | |
| JP2016500682A5 (enExample) | ||
| HRP20140616T1 (hr) | Peptidni analog oksintomodulina | |
| HRP20110242T1 (hr) | Formulacija s fuzijskim proteinom glp-1-fc | |
| JP2014509859A5 (enExample) | ||
| JP2013155195A5 (enExample) | ||
| JP2010536714A5 (enExample) | ||
| JP2023537951A5 (enExample) | ||
| JP2011518179A5 (enExample) | ||
| JP2014514365A5 (enExample) |